SCHEMBL4972222

SCHEMBL4972222

COC(=O)NCCO[C@@H](c1cc(Cl)ccc1C)[C@@H]1CCCN(C(C)(C)C)C1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.52
CYP3A4 P08684 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4193008 0.87 REN (0.59) RENCYP3A4
SCHEMBL4193014 0.87 REN (0.59) RENCYP3A4
SCHEMBL2325897 0.86 REN (0.57) RENCYP3A4
SCHEMBL2325903 0.86 REN (0.57) RENCYP3A4
SCHEMBL2325899 0.86 REN (0.57) RENCYP3A4
SCHEMBL3965737 0.85 REN (0.36) RENCYP3A4
SCHEMBL3965440 0.85 REN (0.62) RENCYP3A4
SCHEMBL4970054 0.83 REN (0.36) REN
SCHEMBL4973483 0.82 REN (0.53) RENCYP3A4
SCHEMBL4972485 0.80 REN (0.61) RENCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed